WANBURY
|
The Current P/E Ratio of WANBURY is 19.73.
| Share Price | ₹243.0 | Mar 04,2026 |
| Market Cap | ₹848.1 Cr | |
| Earnings-TTM | ₹43.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 19.73x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of WANBURY
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹848.1 Cr] as on Mar 04,2026
(/) Earnings [ ₹43.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 19.73x ]
Thus, for WANBURY , the investors are currently willing to pay 19.73 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WANBURY !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of WANBURY over the last five years.
Historical PE (Price/Earnings) ratio chart of WANBURY
PE Ratio Performance Analysis for WANBURY
- WANBURY 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.43x.
- WANBURY 's operated at median p/e ratio of 3.41x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/e ratio peaked in Mar2025 at 25.19x.
- WANBURY 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does WANBURY 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| WANBURY | 42.99 | 19.73 | 848.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 38.15 | 419,728.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 67.46 | 167,236.0 |
| CIPLA LTD | 4,544.70 | 23.33 | 106,033.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 64.68 | 146,951.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.56 | 107,765.0 |
| MANKIND PHARMA LTD | 1,796.65 | 50.66 | 91,013.2 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.28 | 90,213.9 |
| LUPIN LTD | 4,669.18 | 22.56 | 105,323.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 19.76 | 69,411.6 |
| ABBOTT INDIA LTD | 1,524.13 | 38.78 | 59,111.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WANBURY 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.28x |
| Max industry PE | 67.46x |
| Median industry PE | 23.33x |
| Average industry PE | 34.81x |
You may also like the below Video Courses